Close
  Indian J Med Microbiol
 

Figure 3: The effect of Dosakaya juice on various antioxidant parameters related to glutathione homeostasis in kidney under the influence of sucrose feeding. (a) Concentration of reduced glutathione in various experimental groups, *P< 0.05 normal versus Dosakaya + sucrose. (b) The level of glutathione reductase, *P< 0.05 normal versus Dosakaya + sucrose. (c) The level of Glutathione-S-transferase, *P< 0.05 normal versus sucrose. (d) The activity of glutathione peroxidase. (e) The activity of glyoxalase-I (Glo I), *P< 0.05 normal versus sucrose. (f) Thiobarbituric acid reactive substances (TBARS) as measure of lipid peroxides in kidney, *P< 0.001 normal versus sucrose, **P< 0.05 sucrose versus Dosakaya + sucrose, ***P< 0.05 normal versus Dosakaya + sucrose. (g) Advanced glycation end-products (AGEs) in kidney, *P< 0.001 normal versus sucrose, **P< 0.001 sucrose versus Dosakaya + sucrose. (h) Advanced glycation end-products (AGEs) in serum, *P< 0.01 normal versus sucrose, **P< 0.01 sucrose versus Dosakaya + sucrose. Data represent mean ± standard error of the mean of 5–6 animals. Readings were taken in triplicate for each animal

Figure 3: The effect of Dosakaya juice on various antioxidant parameters related to glutathione homeostasis in kidney under the influence of sucrose feeding. (a) Concentration of reduced glutathione in various experimental groups, <sup>*</sup><i>P</i>< 0.05 normal versus Dosakaya + sucrose. (b) The level of glutathione reductase, <sup>*</sup><i>P</i>< 0.05 normal versus Dosakaya + sucrose. (c) The level of Glutathione-S-transferase, <sup>*</sup><i>P</i>< 0.05 normal versus sucrose. (d) The activity of glutathione peroxidase. (e) The activity of glyoxalase-I (Glo I), <sup>*</sup><i>P</i>< 0.05 normal versus sucrose. (f) Thiobarbituric acid reactive substances (TBARS) as measure of lipid peroxides in kidney, <sup>*</sup><i>P</i>< 0.001 normal versus sucrose, <sup>**</sup><i>P</i>< 0.05 sucrose versus Dosakaya + sucrose, <sup>***</sup><i>P</i>< 0.05 normal versus Dosakaya + sucrose. (g) Advanced glycation end-products (AGEs) in kidney, <sup>*</sup><i>P</i>< 0.001 normal versus sucrose, <sup>**</sup><i>P</i>< 0.001 sucrose versus Dosakaya + sucrose. (h) Advanced glycation end-products (AGEs) in serum, <sup>*</sup><i>P</i>< 0.01 normal versus sucrose, <sup>**</sup><i>P</i>< 0.01 sucrose versus Dosakaya + sucrose. Data represent mean ± standard error of the mean of 5–6 animals. Readings were taken in triplicate for each animal